tiprankstipranks
Global Cord Blood (CORBF)
OTHER OTC:CORBF

Global Cord Blood (CORBF) Stock Price & Analysis

175 Followers

CORBF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.02 - $2.33
Previous Close$1.25
Volume7.90K
Average Volume (3M)6.05K
Market Cap
$180.78M
Enterprise Value-$6.49B
Total Cash (Recent Filing)$6.66B
Total Debt (Recent Filing)$23.00K
Price to Earnings (P/E)
Beta-0.41
Aug 28, 2023
EPS EstimateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding121,551,075
10 Day Avg. Volume0
30 Day Avg. Volume6,050
Standard Deviation0.11
R-Squared0.00034
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)2.04
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-6.86
Enterprise Value/Gross Profit-38.83
Enterprise Value/Ebitda-13.91
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

15.90%0.02%<0.01%84.07%
15.90%
Insiders
<0.01% Other Institutional Investors
84.07% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

CORBF FAQ

What was Global Cord Blood’s price range in the past 12 months?
Global Cord Blood lowest stock price was $0.02 and its highest was $2.33 in the past 12 months.
    What is Global Cord Blood’s market cap?
    Currently, no data Available
    When is Global Cord Blood’s upcoming earnings report date?
    Global Cord Blood’s upcoming earnings report date is Aug 28, 2023 which is 331 days ago.
      How were Global Cord Blood’s earnings last quarter?
      Currently, no data Available
      Is Global Cord Blood overvalued?
      According to Wall Street analysts Global Cord Blood’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Global Cord Blood pay dividends?
        Global Cord Blood pays a Notavailable dividend of $0.08 which represents an annual dividend yield of N/A. See more information on Global Cord Blood dividends here
          What is Global Cord Blood’s EPS estimate?
          Global Cord Blood’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Global Cord Blood have?
          Global Cord Blood has 133,914,720 shares outstanding.
            What happened to Global Cord Blood’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Global Cord Blood?
            Among the largest hedge funds holding Global Cord Blood’s share is Caxton Associates LP. It holds Global Cord Blood’s shares valued at N/A.
              ---

              Company Description

              Global Cord Blood

              Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. It preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Cooper Co
              Cytosorbents
              Cogent Biosciences
              IQVIA Holdings
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis